- Details for Epirubicin hydrochloride
-
Epirubicin hydrochloride 56390-09-1
| Category : |
Intermediates/Pharmaceutical intermediates |
 |
| CAS NO : |
56390-09-1 |
| EC NO : |
260-145-2 |
| MF : |
C27H29NO11 |
| MW : |
543.5193 |
| Uses : |
Monotherapy has broad-spectrum inhibition against a wide range of tumors, including breast cancer, malignant lymphoma, soft tissue sarcoma, and gastric cancer. Studies have shown that the drug also has anti-tumor activity against malignant melanoma and co |
| Synonyms : |
epirubicin hydrochloride;l-erythro-dihydrosphingosine;(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside hydrochloride (1:1);(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranoside; |
| Molecular Structure : |
 |